Pediatrics Doctors in South Yarmouth, MA Accepting Medicare

6 Pediatrics doctors found. Showing 1 - 6

Jennifer Ann Berrick, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 257 Station Ave, South Yarmouth, MA 02664 Phone: 508-500-6622    Fax: 508-785-6120

Mathew H Baldasaro, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 237 Station Ave, South Yarmouth, MA 02664 Phone: 508-394-2116    Fax: 508-760-1919

Lorraine Zito, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 237 Station Ave, South Yarmouth, MA 02664 Phone: 508-394-2116    Fax: 508-760-1919

Karin R Gilbert, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 237 Station Ave, South Yarmouth, MA 02664 Phone: 508-394-2116    Fax: 508-760-1919

Paul L Marz, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 237 Station Ave, South Yarmouth, MA 02664 Phone: 508-394-2116    Fax: 508-760-1919

Kenneth P Colmer, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 237 Station Ave, South Yarmouth, MA 02664 Phone: 508-394-2116    Fax: 508-760-1919

News Archive

Specific gut bacteria can improve cancer immunotherapy, show studies

By introducing a particular strain of bacteria into the digestive tracts of mice with melanoma, researchers at the University of Chicago were able to boost the ability of the animal's immune systems to attack tumor cells. T

New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug

HealthCore, Inc., the outcomes research subsidiary of Anthem, Inc. and Novo Nordisk Inc., which manufacturers the once weekly GLP-1 receptor agonist Ozempic (semaglutide), are working together to launch the first of its kind pragmatic study to understand the benefits of semaglutide as compared with all other available diabetes drugs in a real-world pragmatic clinical trial for Type 2 diabetes - one of the nation's fastest growing chronic diseases.

HealthSpring third quarter net income increases 27.1% to $42.3 million

HealthSpring, Inc. today announced its results for the third quarter ended September 30, 2010. Net income of $53.8 million, or $0.95 per diluted share, up 27.1% over $42.3 million, or $0.77 per diluted share, in the 2009 third quarter.

Patient with breast lesion should undergo surgical excision to eliminate underlying malignancy: Study

Any patient with a breast lesion classified as a radial scar classified at percutaneous biopsy should undergo a surgical excision to rule out an underlying malignancy, according to a study published in the April issue of the American Journal of Roentgenology (www.ajronline.org).

Read more Medical News

› Verified 6 days ago